Moderna AI Cancer Trial Success Sparks $44B Market Value Jump
imjustnewatai · x · 2026-08-20
Moderna announced that its AI-personalized cancer therapy, intismeran, combined with Keytruda, met Phase 3 endpoints by significantly reducing melanoma recurrence. The therapy uses fully integrated AI algorithms to design unique mRNA sequences for each patient based on post-surgery tumor sequencing, effectively creating a different drug version for every individual. This news sent Moderna's market value up by roughly $44 billion in a single day.
More from Apps
- Dev ships AI-built browser shooter Canyon Overdrive, playable right inside an X post — AIandDesign · 2026-10-16
- Juan Benet: Google Docs has become unusable with AI tools, time for open formats — juanbenet · 2026-10-16
- ERP•AI and Proto Launch 'Headless SaaS' Where Agents Operate Business Software — SucceededMind · 2026-10-16
- Envato Launches AI Creative Toolkit Bundling Nano Banana, Veo and More — alifcoder · 2026-10-16
- Developer Shares That Her 57-Year-Old Chinese Dad Started Using Muse — KlausCodes · 2026-10-16
- ChatGPT brings computer use to Chrome: reads tabs and controls the browser — craigsdennis · 2026-10-16